LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 277

Search options

  1. Article: Prof. Jan Glatzel (1888-1954) (w 40 rocznice śmierci).

    Wysocki, A / Poźniczek, M

    Przeglad lekarski

    1994  Volume 51, Issue 10, Page(s) 456–458

    Title translation Prof. Jan Glatzel (1888-1954) (40th anniversary of death).
    MeSH term(s) Education, Medical/history ; General Surgery/history ; History, 20th Century ; Poland
    Language Polish
    Publishing date 1994
    Publishing country Poland
    Document type Biography ; Historical Article ; Journal Article ; Portrait
    ZDB-ID 414053-9
    ISSN 0033-2240 ; 0860-0422
    ISSN 0033-2240 ; 0860-0422
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.B 640: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: In memoriam Jan Roguski.

    Wysocki, K

    Cor et vasa

    1972  Volume 14, Issue 1, Page(s) 77–78

    MeSH term(s) History, 20th Century ; Internal Medicine/history ; Poland
    Language English
    Publishing date 1972
    Publishing country Czech Republic
    Document type Biography ; Historical Article ; Journal Article
    ZDB-ID 421521-7
    ISSN 0010-8650
    ISSN 0010-8650
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 197: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: ACE2 in the Urine: Where Does It Come From?

    Wysocki, Jan / Batlle, Daniel

    Kidney360

    2022  Volume 3, Issue 12, Page(s) 2001–2004

    MeSH term(s) Angiotensin-Converting Enzyme 2 ; Renin-Angiotensin System ; Peptidyl-Dipeptidase A/metabolism
    Chemical Substances Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Peptidyl-Dipeptidase A (EC 3.4.15.1)
    Language English
    Publishing date 2022-12-29
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural ; Comment
    ISSN 2641-7650
    ISSN (online) 2641-7650
    DOI 10.34067/KID.0005592022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  4. Book ; Thesis: Myosonographische und computertomographische Erfassung von Familien mit maligner Hyperthermie

    Wysocki, Jan

    1994  

    Author's details vorgelegt von Jan Wysocki
    Language German
    Size 102 Bl. : Ill., graph. Darst.
    Edition [Mikrofiche-Ausg.]
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Rostock, Univ., Diss., 1995
    Note Mikrofiche-Ausg.: 2 Mikrofiches : 24x
    HBZ-ID HT006847327
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    1996 MB 21 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article: Profesor dr med. Jan roguski (18.VI.1900-7.IX.1971.

    Wysocki, K

    Polskie Archiwum Medycyny Wewnetrznej

    1972  Volume 48, Issue 3, Page(s) 333–336

    Title translation Professor Jan roguski, M.D. (June 18, 1900-September 7, 1971).
    MeSH term(s) Cardiology/history ; History, 20th Century ; Microbiology/history ; Poland
    Language Polish
    Publishing date 1972
    Publishing country Poland
    Document type Biography ; Historical Article ; Journal Article
    ZDB-ID 123500-x
    ISSN 1897-9483 ; 1897-9483 ; 0032-3772
    ISSN (online) 1897-9483
    ISSN 1897-9483 ; 0032-3772
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 360: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?

    Batlle, Daniel / Wysocki, Jan / Satchell, Karla

    Clinical science (London, England : 1979)

    2020  Volume 134, Issue 5, Page(s) 543–545

    Abstract: A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of ... ...

    Abstract A new coronavirus, referred to as SARS-CoV-2, is responsible for the recent outbreak of severe respiratory disease. This outbreak first detected in Wuhan, China in December 2019, has spread to other regions of China and to 25 other countries as of January, 2020. It has been known since the 2003 SARS epidemic that the receptor critical for SARS-CoV entry into host cells is the angiotensin-converting enzyme 2 (ACE2). The S1 domain of the spike protein of SARS-CoV attaches the virus to its cellular receptor ACE2 on the host cells. We thought that it is timely to explain the connection between the SARS-CoV, SARS-CoV-2, ACE2 and the rationale for soluble ACE2 as a potential therapy.
    MeSH term(s) Animals ; Betacoronavirus/pathogenicity ; Cell Line ; Coronavirus Infections/drug therapy ; Haplorhini ; Humans ; Peptidyl-Dipeptidase A/physiology ; Pneumonia, Viral/drug therapy ; Recombinant Proteins/therapeutic use ; SARS Virus/pathogenicity ; Solubility ; Virus Attachment ; Virus Replication
    Chemical Substances Recombinant Proteins ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-)
    Keywords covid19
    Language English
    Publishing date 2020-04-07
    Publishing country England
    Document type Letter ; Research Support, N.I.H., Extramural
    ZDB-ID 206835-7
    ISSN 1470-8736 ; 0301-0538 ; 0009-0360 ; 0143-5221
    ISSN (online) 1470-8736
    ISSN 0301-0538 ; 0009-0360 ; 0143-5221
    DOI 10.1042/CS20200163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.220: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article ; Online: Fecal ammonium in mice with CKD: gastrointestinal sequestration by sodium zirconium cyclosilicate.

    Marmol, Fernando / Badaruddin, Mohammed / Baig, Athar / Ye, Minghao / Wysocki, Jan / Tahaei, Ebrahim / Welling, Paul / Bamberg, Krister / Batlle, Daniel

    American journal of physiology. Renal physiology

    2023  Volume 324, Issue 5, Page(s) F464–F471

    Abstract: Urinary [Formula: see text] excretion is decreased in chronic kidney disease (CKD), but very little is known about fecal [Formula: see text] excretion. Sodium zirconium cyclosilicate (SZC) is a cation exchanger that selectively captures ... ...

    Abstract Urinary [Formula: see text] excretion is decreased in chronic kidney disease (CKD), but very little is known about fecal [Formula: see text] excretion. Sodium zirconium cyclosilicate (SZC) is a cation exchanger that selectively captures K
    MeSH term(s) Animals ; Mice ; Hyperkalemia ; Potassium ; Renal Insufficiency, Chronic ; Gastrointestinal Tract
    Chemical Substances Potassium (RWP5GA015D) ; sodium zirconium cyclosilicate (D652ZWF066)
    Language English
    Publishing date 2023-04-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603837-2
    ISSN 1522-1466 ; 0363-6127
    ISSN (online) 1522-1466
    ISSN 0363-6127
    DOI 10.1152/ajprenal.00312.2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Uc I Zs.89: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: New Frontiers in Therapy of Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Latest Evidence and Clinical Implications.

    Marjanska, Agata / Galazka, Przemyslaw / Wysocki, Mariusz / Styczynski, Jan

    Anticancer research

    2020  Volume 40, Issue 4, Page(s) 1817–1831

    Abstract: Almost all individuals with neurofibromatosis type 1 (NF1) develop peripheral nerve sheath tumors (PNSTs), mainly benign neurofibromas, however about 10% of PNSTs will undergo transformation to malignant peripheral nerve sheath tumors (MPNSTs). Surgical ... ...

    Abstract Almost all individuals with neurofibromatosis type 1 (NF1) develop peripheral nerve sheath tumors (PNSTs), mainly benign neurofibromas, however about 10% of PNSTs will undergo transformation to malignant peripheral nerve sheath tumors (MPNSTs). Surgical treatment of PNSTs has traditionally been regarded as a standard approach. The availability of new agents that target specific molecular pathways involved in the pathogenesis of PNST has led to a number of clinical trials, which resulted in increased chances for better survival and quality of life. This review presents the latest evidence and clinical implications for new therapies of PNSTs in patients with NF1 emphasizing the potential benefit from the use of Ras/MAPK pathway inhibitors, immunotherapy, chemotherapy or radiation therapy. We present evaluation of current knowledge on available treatment modalities.
    MeSH term(s) Humans ; MAP Kinase Signaling System/drug effects ; MAP Kinase Signaling System/genetics ; Neoplasms/complications ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/pathology ; Nerve Sheath Neoplasms/complications ; Nerve Sheath Neoplasms/drug therapy ; Nerve Sheath Neoplasms/genetics ; Nerve Sheath Neoplasms/pathology ; Neurofibromatosis 1/complications ; Neurofibromatosis 1/drug therapy ; Neurofibromatosis 1/genetics ; Neurofibromatosis 1/pathology ; Protein Kinase Inhibitors/therapeutic use ; Signal Transduction/drug effects ; Tomography, X-Ray Computed ; ras Proteins/antagonists & inhibitors ; ras Proteins/genetics
    Chemical Substances Protein Kinase Inhibitors ; ras Proteins (EC 3.6.5.2)
    Language English
    Publishing date 2020-03-31
    Publishing country Greece
    Document type Journal Article ; Review
    ZDB-ID 604549-2
    ISSN 1791-7530 ; 0250-7005
    ISSN (online) 1791-7530
    ISSN 0250-7005
    DOI 10.21873/anticanres.14136
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1642: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: An update on ACE2 amplification and its therapeutic potential.

    Marquez, Alonso / Wysocki, Jan / Pandit, Jay / Batlle, Daniel

    Acta physiologica (Oxford, England)

    2020  Volume 231, Issue 1, Page(s) e13513

    Abstract: The renin angiotensin system (RAS) plays an important role in the pathogenesis of variety of diseases. Targeting the formation and action of angiotensin II (Ang II), the main RAS peptide, has been the key therapeutic target for last three decades. ACE- ... ...

    Abstract The renin angiotensin system (RAS) plays an important role in the pathogenesis of variety of diseases. Targeting the formation and action of angiotensin II (Ang II), the main RAS peptide, has been the key therapeutic target for last three decades. ACE-related carboxypeptidase (ACE2), a monocarboxypeptidase that had been discovered 20 years ago, is one of the catalytically most potent enzymes known to degrade Ang II to Ang-(1-7), a peptide that is increasingly accepted to have organ-protective properties that oppose and counterbalance those of Ang II. In addition to its role as a RAS enzyme ACE2 is the main receptor for SARS-CoV-2. In this review, we discuss various strategies that have been used to achieve amplification of ACE2 activity including the potential therapeutic potential of soluble recombinant ACE2 protein and novel shorter ACE2 variants.
    MeSH term(s) Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/metabolism ; Angiotensin-Converting Enzyme 2/therapeutic use ; Animals ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; COVID-19/enzymology ; COVID-19/genetics ; COVID-19/therapy ; COVID-19/virology ; Enzyme Activation ; Enzyme Activators/therapeutic use ; Gene Amplification ; Genetic Therapy ; Host-Pathogen Interactions ; Humans ; Receptors, Virus/genetics ; Receptors, Virus/metabolism ; Receptors, Virus/therapeutic use ; Recombinant Proteins/therapeutic use ; SARS-CoV-2/pathogenicity ; Virus Internalization/drug effects
    Chemical Substances Antiviral Agents ; Enzyme Activators ; Receptors, Virus ; Recombinant Proteins ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-06-17
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 2218636-0
    ISSN 1748-1716 ; 1748-1708
    ISSN (online) 1748-1716
    ISSN 1748-1708
    DOI 10.1111/apha.13513
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Uc I Zs 229: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article ; Online: ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.

    Lores, Enrique / Wysocki, Jan / Batlle, Daniel

    Clinical science (London, England : 1979)

    2020  Volume 134, Issue 21, Page(s) 2791–2805

    Abstract: Angiotensin-converting enzyme II (ACE2) is a homologue of angiotensin-converting enzyme discovered in 2000. From the initial discovery, it was recognized that the kidneys were organs very rich on ACE2. Subsequent studies demonstrated the precise ... ...

    Abstract Angiotensin-converting enzyme II (ACE2) is a homologue of angiotensin-converting enzyme discovered in 2000. From the initial discovery, it was recognized that the kidneys were organs very rich on ACE2. Subsequent studies demonstrated the precise localization of ACE2 within the kidney and the importance of this enzyme in the metabolism of Angiotensin II and the formation of Angiotensin 1-7. With the recognition early in 2020 of ACE2 being the main receptor of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), the interest in this protein has dramatically increased. In this review, we will focus on kidney ACE2; its localization, its alterations in hypertension, diabetes, the effect of ACE inhibitors and angiotensin type 1 receptor blockers (ARBs) on ACE2 and the potential use of ACE2 recombinant proteins therapeutically for kidney disease. We also describe the emerging kidney manifestations of COVID-19, namely the frequent development of acute kidney injury. The possibility that binding of SARS-CoV-2 to kidney ACE2 plays a role in the kidney manifestations is also briefly discussed.
    MeSH term(s) Acute Kidney Injury/enzymology ; Acute Kidney Injury/virology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Animals ; Antiviral Agents/therapeutic use ; Betacoronavirus/drug effects ; Betacoronavirus/pathogenicity ; Coronavirus Infections/drug therapy ; Coronavirus Infections/enzymology ; Coronavirus Infections/virology ; Diabetes Mellitus/enzymology ; Diabetes Mellitus/physiopathology ; History, 21st Century ; Host-Pathogen Interactions ; Humans ; Hypertension/enzymology ; Hypertension/physiopathology ; Kidney/enzymology ; Kidney/physiopathology ; Kidney Diseases/drug therapy ; Kidney Diseases/enzymology ; Kidney Diseases/physiopathology ; Pandemics ; Peptidyl-Dipeptidase A/history ; Peptidyl-Dipeptidase A/metabolism ; Peptidyl-Dipeptidase A/therapeutic use ; Pneumonia, Viral/enzymology ; Pneumonia, Viral/virology ; Receptors, Virus/history ; Receptors, Virus/metabolism
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors ; Antiviral Agents ; Receptors, Virus ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; angiotensin converting enzyme 2 (EC 3.4.17.-)
    Keywords covid19
    Language English
    Publishing date 2020-11-12
    Publishing country England
    Document type Historical Article ; Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 206835-7
    ISSN 1470-8736 ; 0301-0538 ; 0009-0360 ; 0143-5221
    ISSN (online) 1470-8736
    ISSN 0301-0538 ; 0009-0360 ; 0143-5221
    DOI 10.1042/CS20200484
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.220: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top